The apolipoprotein E epsilon4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities

scientific article published in April 2007

The apolipoprotein E epsilon4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1600-0404.2006.00779.X
P8608Fatcat IDrelease_og3guf3mgjhodmkq6tje3eng7q
P698PubMed publication ID17376122

P50authorErik Lykke MortensenQ20984698
Gunhild WaldemarQ28862028
Ellen GardeQ47502344
P2093author name stringHøgh P
Krabbe K
Jørgensen OS
P2860cites workGene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset familiesQ27860677
A simple salting out procedure for extracting DNA from human nucleated cellsQ27861086
APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysisQ28145941
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's diseaseQ29614952
Neuropathology of white matter lesions in vascular cognitive impairmentQ34568772
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer diseaseQ34662682
Blood pressure variability and white matter hyperintensities in older adults with cardiovascular diseaseQ35547548
Does APO epsilon4 correlate with MRI changes in Alzheimer's disease?Q35572157
Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based studyQ36888014
Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensitiesQ40648342
Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptidesQ41172424
The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive functionQ41727043
Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin StudyQ43570563
Neurodegeneration in the central nervous system of apoE-deficient miceQ46455236
Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjectsQ46505854
Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular diseaseQ47695149
Interaction between hypertension, apoE, and cerebral white matter lesionsQ47832284
Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementiasQ48135484
Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin studyQ48143642
A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imagingQ48360275
Progression of cerebral white matter hyperintensities on MRI is related to diastolic blood pressureQ48425051
The association of antihypertensive agents with MRI white matter findings and with Modified Mini-Mental State Examination in older adultsQ48580431
Lesion probability maps of white matter hyperintensities in elderly individuals: results of the Austrian stroke prevention studyQ48587526
Hypertension and cerebral white matter lesions in a prospective cohort studyQ48651384
Interactive effects of age and hypertension on volumes of brain structuresQ48670245
Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depressionQ48675144
Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention StudyQ48717937
Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities StudyQ48849756
Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the worldQ50543967
Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.Q50682809
Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injuryQ53200531
Clinical application of apolipoprotein E genotyping to Alzheimer's disease.Q53204355
beta-Amyloid-mediated vasoactivity and vascular endothelial damage.Q53211170
Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.Q53211318
Neurocardiovascular instability, hypotensive episodes, and MRI lesions in neurodegenerative dementia.Q53235139
Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rateQ53501154
Apolipoprotein E epsilon4 allele is associated with vascular dementia.Q54586339
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)248-253
P577publication date2007-04-01
P1433published inActa Neurologica ScandinavicaQ4676732
P1476titleThe apolipoprotein E epsilon4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities
P478volume115

Reverse relations

cites work (P2860)
Q30655480APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis
Q90424400APOE ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia
Q33771171Accumulation of intraneuronal Abeta correlates with ApoE4 genotype
Q46732646Associations of apolipoprotein E gene with ischemic stroke and intracranial atherosclerosis.
Q35579629Genetic associations of leukoaraiosis indicate pathophysiological mechanisms in white matter lesions etiology
Q37019867Glucose Dysregulation Interacts With APOE-∊4 to Potentiate Temporoparietal Cortical Thinning
Q50207666Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study.
Q37715160Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association
Q47985394Increased diastolic blood pressure is associated with MRI biomarkers of dementia-related brain pathology in normative ageing
Q35167347Interactive effects of apolipoprotein E4 and diabetes risk on later myelinating white matter regions in neurologically healthy older aged adults
Q31146571Reduced noncovalent connections in leukoaraiosis
Q34533309Relationship between orthostatic hypotension and white matter hyperintensity load in older patients with mild dementia.
Q61443837Spatial patterns of white matter hyperintensities associated with Alzheimer's disease risk factors in a cognitively healthy middle-aged cohort
Q92511509The Associations of PMF1, ICAM1, AGT, TRIM65, FBF1, and ACOX1 Variants With Leukoaraiosis in Chinese Population
Q36813704The role of APOE in cerebrovascular dysfunction
Q28601040White Matter Lesion Progression: Genome-Wide Search for Genetic Influences

Search more.